Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Wing K"'
Autor:
McCluskey SA; Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Eaton North 3-405, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada. stuart.mccluskey@uhn.on.ca, Cheung WK, Katznelson R, Poonawala H, Fedorko L, Djaiani G, Mehta B, Karkouti K
Publikováno v:
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2009 Mar; Vol. 65 (3), pp. 273-9. Date of Electronic Publication: 2008 Oct 30.
Autor:
Krzyzanski W; Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14260, USA. wk@acsu.buffalo.edu, Jusko WJ, Wacholtz MC, Minton N, Cheung WK
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2005 Nov; Vol. 26 (3-4), pp. 295-306.
Autor:
Xenocostas A; Hematology Division, Rm 2760, London Health Sciences Centre/University of Western Ontario, LHSC, Westminster Site, 800 Commissioners Road East, London, ON, N6A 4G5, Canada. anargyros.xenocostas@lhsc.on.ca, Cheung WK, Farrell F, Zakszewski C, Kelley M, Lutynski A, Crump M, Lipton JH, Kiss TL, Lau CY, Messner HA
Publikováno v:
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2005 May; Vol. 61 (3), pp. 189-95. Date of Electronic Publication: 2005 Mar 18.
Autor:
Ramakrishnan R; Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, NY 14260, USA., Cheung WK, Wacholtz MC, Minton N, Jusko WJ
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2004 Sep; Vol. 44 (9), pp. 991-1002.
Autor:
Ramakrishnan R; Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, 565 Hoch-stetter Hall, State University of New York at Buffalo, Buffalo NY 14260, USA., Cheung WK, Farrell F, Joffee L, Jusko WJ
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2003 Jul; Vol. 306 (1), pp. 324-31. Date of Electronic Publication: 2003 Apr 03.
Autor:
Ludwik Fedorko, Wing K. Cheung, Bobby Mehta, George Djaiani, Stuart A. McCluskey, Humara Poonawala, Keyvan Karkouti, Rita Katznelson
Publikováno v:
European Journal of Clinical Pharmacology. 65:273-279
In anticipation of future studies, we examined the pharmacokinetics profile of erythropoietin (EPO) in patients undergoing cardiac surgery.Cardiac surgical patients were enrolled into one of six groups: four cardiopulmonary bypass (CPB) groups [place
Autor:
Marian Kelley, Michael Crump, Francis Farrell, Andrzej Lutynski, Thomas Kiss, Wing K. Cheung, Anargyros Xenocostas, Catherine Y. Lau, Cindy Zakszewski, Jeffrey H. Lipton, Hans A. Messner
Publikováno v:
European Journal of Clinical Pharmacology. 61:189-195
Erythropoietin (EPO) was originally described as a regulator of erythropoiesis. Recently, synthesis of EPO and expression of the EPO receptor (EPO-R) have been reported for the central nervous system (CNS). The potential use of EPO to prevent or redu
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 306:324-331
The pharmacokinetics (PK) and pharmacodynamics (PD) of recombinant human erythropoietin (rHuEpo) were investigated in monkeys. A two-compartment model with dual input and nonlinear disposition could adequately characterize the PK of rHuEpo upon three
Publikováno v:
The Journal of international medical research. 34(1)
The erythropoietic effect of recombinant human erythropoietin, epoetin alpha (rHuEPO), in promoting the growth of erythroid burst-forming units (BFU-E) was compared with darbepoetin alpha (DARB), a rHuEPO analogue obtained by site-directed mutagenesi
Publikováno v:
Journal of clinical pharmacology. 44(9)
This study describes a pharmacokinetic (PK) model to account for serum recombinant human erythropoietin (rHuEpo) concentrations in healthy volunteers following intravenous (IV) and subcutaneous (SC) dosing; it also characterizes the pharmacodynamics